Drug Discovery & Development

Lab Gallery & Showcase

Explore our innovative drug delivery technologies, patented formulations, and research collaborations

Ethosomal Drug Delivery System

Novel Nanocarrier

Advanced lipid-based vesicular system for enhanced transdermal drug delivery with improved skin penetration.

Polymeric Nanoparticles

PLGA/PLA Based

Biodegradable nanoparticles for controlled drug release and targeted delivery to specific tissues.

Ocular Inserts

Sustained Release

Innovative ocular drug delivery devices for prolonged release of anti-glaucoma and anti-inflammatory agents.

Microspheres

Controlled Release

Microparticulate systems for sustained drug delivery with improved bioavailability and reduced dosing frequency.

Liposomal Formulations

Phospholipid Bilayer

Vesicular drug carriers for improved solubility, stability, and targeted delivery of hydrophobic and hydrophilic drugs.

Ethosomal Drug Delivery System

Novel Nanocarrier

Advanced lipid-based vesicular system for enhanced transdermal drug delivery with improved skin penetration.

Case Studies

Transdermal Drug Delivery Enhancement

Completed

Development of ethosomal gel formulations for enhanced skin permeation of NSAIDs, achieving 3x higher bioavailability compared to conventional formulations.

3x improvement in drug permeation
Sustained release over 24 hours
Reduced dosing frequency
2023

Ocular Drug Delivery for Glaucoma

Completed

Novel ocular insert system for sustained release of esmolol HCl, providing controlled drug delivery for 7 days with single administration.

7-day sustained release profile
Reduced side effects
Improved patient compliance
2022

Nanoparticle-based Cancer Therapy

Ongoing

Development of targeted nanoparticles for delivery of chemotherapeutic agents with reduced systemic toxicity.

Enhanced tumor targeting
Reduced systemic toxicity
Improved therapeutic index
2024